Bo Wiesman and Michael van Schie

Bo Wiesman and Michael van Schie

REDUCING PATIENT SUFFERING WITH ENTREPRENEURIAL SOLUTIONS

Programme: MSc Entrepreneurship & New Business Venturing, 2005
Currently: Founders of NewCompliance
Nominated by: Stijn van Osselaer, Professor of marketing and Wim Hulsink, Associate Professor of strategic management and entrepreneurship

Bo Wiesman and Michael van Schie provide high-tech entrepreneurial solutions for the common good. After completing RSM’s MSc Entrepreneurship & New Business Venturing RSM programme cum laude, they joined forces to build up NewCompliance. This innovative company develops and markets technological concepts which improve patient safety and productivity in the operating room and other critical areas in healthcare facilities. 

“We want to improve healthcare and patient safety on a global level, thus saving many lives and reducing patient suffering and costs,” says Bo, adding that it’s important to think big, but start small. “Our first goal has always been to survive and grow a company that is financially healthy, and can support the employees and their families.”

Bo and Michael have known each other since primary school but lost touch until they met again in RSM’s master programme. RSM provided the starting point for their entrepreneurship. “Without RSM, we would never have started our own company,” say Bo and Michael, who regularly provide guest lectures at RSM. “The school also was very open to our ideas. The Exam Committee allowed us to write our thesis together and have a co-reader from the medical university.” Bo and Michael’s master thesis about improving hand washing behaviour through the use of printed toilet paper was awarded with a 9 out of 10.

Now that NewCompliance is an established and dynamic company, Bo and Michael can focus more on their main goal of improving patients’ medical experiences. “We’re driven by the knowledge that we are actually saving lives through the innovative products and actions that we have created and are still creating,” says Michael. “By further promoting these, we can save lives and patient suffering on a much larger scale, and make the world a little bit better.”